Osteocalcin, Vascular Calcification, and Atherosclerosis: A Systematic Review and Meta-analysis

Background Osteocalcin (OC) is an intriguing hormone, concomitantly being the most abundant non-collagenous peptide found in the mineralized matrix of bone, and expanding the endocrine function of the skeleton with far-reaching extra-osseous effects. A new line of enquiry between OC and vascular calcification has emerged in response to observations that the mechanism of vascular calcification resembles that of bone mineralisation. To date, studies have reported mixed results. This systematic review and meta-analysis aimed to identify any association between OC and vascular calcification and atherosclerosis. Methods and results Databases were searched for original, peer reviewed human studies. A total of 1,453 articles were retrieved, of which 46 met the eligibility criteria. Overall 26 positive, 17 negative, and 29 neutral relationships were reported for assessments between OC (either concentration in blood, presence of OC-positive cells, or histological staining for OC) and extent of calcification or atherosclerosis. Studies that measured OC-positive cells or histological staining for OC reported positive relationships (11 studies). A higher percentage of Asian studies found a negative relationship (36%) in contrast to European studies (6%). Studies examining carboxylated and undercarboxylated forms of OC in the blood failed to report consistent results. The meta-analysis found no significant difference between OC concentration in the blood between patients with “atherosclerosis” and control (p = 0.13, n = 1,197). Conclusion No definitive association was determined between OC and vascular calcification or atherosclerosis; however, the presence of OC-positive cells and histological staining had a consistent positive correlation with calcification or atherosclerosis. The review highlighted several themes, which may influence OC within differing populations leading to inconclusive results. Large, longitudinal studies are required to further current understanding of the clinical relevance of OC in vascular calcification and atherosclerosis.

[1]  M. Pfeffer,et al.  Cardiovascular risk in chronic kidney disease. , 2004, Kidney international. Supplement.

[2]  I. Olkin,et al.  Meta-analysis of observational studies in epidemiology - A proposal for reporting , 2000 .

[3]  P. Ducy.  The role of osteocalcin in the endocrine cross-talk between bone remodelling and energy metabolism , 2011, Diabetologia.

[4]  M. Kim,et al.  Low Level of Osteocalcin Is Related With Arterial Stiffness in Korean Adults: An Inverse J-Shaped Relationship. , 2016, The Journal of clinical endocrinology and metabolism.

[5]  K. Meguro,et al.  Erratum to: Effects on bone metabolism markers and arterial stiffness by switching to rivaroxaban from warfarin in patients with atrial fibrillation , 2017, Heart and Vessels.

[6]  Xin Gao,et al.  Serum levels of osteocalcin in relation to glucose metabolism and carotid atherosclerosis in Chinese middle-aged and elderly male adults: the Shanghai Changfeng Study. , 2014, European journal of internal medicine.

[7]  L. Lerman,et al.  Circulating osteogenic endothelial progenitor cell counts: new biomarker for the severity of coronary artery disease. , 2017, International journal of cardiology.

[8]  M. McKee,et al.  Endocrine Regulation of Energy Metabolism by the Skeleton , 2007, Cell.

[9]  M. Inaba,et al.  Significant Association Between Bone-Specific Alkaline Phosphatase and Vascular Calcification of the Hand Arteries in Male Hemodialysis Patients , 2014, Kidney and Blood Pressure Research.

[10]  M. Bots,et al.  Vitamin K intake and osteocalcin levels in women with and without aortic atherosclerosis: a population-based study. , 1995, Atherosclerosis.

[11]  K. Gedrich,et al.  Determinants and Correlates of Serum Undercarboxylated Osteocalcin , 2008, Annals of Nutrition and Metabolism.

[12]  P. Delmas,et al.  Impairment of gamma carboxylation of circulating osteocalcin (bone gla protein) in elderly women , 1991, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[13]  Chuan Wang,et al.  Correlation between osteocalcin‐positive endothelial progenitor cells and spotty calcification in patients with coronary artery disease , 2015, Clinical and experimental pharmacology & physiology.

[14]  P. Price,et al.  Direct demonstration that the vitamin k‐dependent bone gla protein is incompletely γ‐carboxylated in humans , 1994 .

[15]  J. Higaki,et al.  Undercarboxylated Osteocalcin Is a Biomarker of Carotid Calcification in Patients with Essential Hypertension , 2010, Kidney and Blood Pressure Research.

[16]  R. Levy,et al.  The identification of the vitamin K-dependent bone protein osteocalcin as one of the gamma-carboxyglutamic acid containing proteins present in calcified atherosclerotic plaque and mineralized heart valves. , 1983, Atherosclerosis.

[17]  J. Mann,et al.  Maternal and Offspring Pools of Osteocalcin Influence Brain Development and Functions , 2013, Cell.

[18]  J. Beilby,et al.  Reduced serum total osteocalcin is associated with metabolic syndrome in older men via waist circumference, hyperglycemia, and triglyceride levels. , 2010, European journal of endocrinology.

[19]  W. C. O'Neill,et al.  Breast arterial calcification in chronic kidney disease: absence of smooth muscle apoptosis and osteogenic transdifferentiation. , 2014, Kidney international.

[20]  S. Yano,et al.  Serum osteocalcin level is associated with glucose metabolism and atherosclerosis parameters in type 2 diabetes mellitus. , 2009, The Journal of clinical endocrinology and metabolism.

[21]  Z. Awan,et al.  Calcium homeostasis and skeletal integrity in individuals with familial hypercholesterolemia and aortic calcification. , 2010, Clinical chemistry.

[22]  N. Joo,et al.  Coronary artery calcification is associated with high serum concentration of undercarboxylated osteocalcin in asymptomatic Korean men , 2015, Clinical endocrinology.

[23]  G. Sesti,et al.  Relation of low bone mineral density and carotid atherosclerosis in postmenopausal women. , 2004, The American journal of cardiology.

[24]  F. Cantatore,et al.  Osteoblast physiology in normal and pathological conditions , 2011, Cell and Tissue Research.

[25]  J. Poser,et al.  Production of osteocalcin by human bone cells in vitro. Effects of 1,25(OH)2D3, 24,25(OH)2D3, parathyroid hormone, and glucocorticoids. , 1984, Metabolic bone disease & related research.

[26]  Y. Bao,et al.  O R I G I N a L I N V E S T I G a T I O N Open Access , 2022 .

[27]  Paolo Raggi,et al.  High coronary artery calcium scores pose an extremely elevated risk for hard events. , 2002, Journal of the American College of Cardiology.

[28]  Aortic Calcification and Bone Metabolism: The Relationship between Aortic Calcification, BMD, Vertebral Fracture, 25-Hydroxyvitamin D, and Osteocalcin , 2012, Calcified Tissue International.

[29]  R. Correa-Rotter,et al.  Biomarkers Associated with Vascular Calcification in Peritoneal Dialysis , 2016, Peritoneal Dialysis International.

[30]  Y. Arad,et al.  Prediction of coronary events with electron beam computed tomography. , 2000, Journal of the American College of Cardiology.

[31]  M. Lenhard,et al.  Osteoprotegerin is a Better Serum Biomarker of Coronary Artery Calcification than Osteocalcin in Type 2 Diabetes. , 2015, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[32]  J. Jiménez-Moleón,et al.  Relationship between serum levels of osteocalcin and atherosclerotic disease in type 2 diabetes. , 2012, Diabetes & metabolism.

[33]  M. Yoder.  Human endothelial progenitor cells. , 2012, Cold Spring Harbor perspectives in medicine.

[34]  Y. Bao,et al.  Serum levels of osteocalcin are inversely associated with the metabolic syndrome and the severity of coronary artery disease in Chinese men , 2011, Clinical endocrinology.

[35]  I. Kanazawa,et al.  Undercarboxylated osteocalcin is positively associated with free testosterone in male patients with type 2 diabetes mellitus , 2013, Osteoporosis International.

[36]  C. Foresta,et al.  Increased levels of osteocalcin-positive endothelial progenitor cells in patients affected by erectile dysfunction and cavernous atherosclerosis. , 2010, The journal of sexual medicine.

[37]  E. V. van Beek,et al.  18F-Sodium Fluoride Uptake Is a Marker of Active Calcification and Disease Progression in Patients With Aortic Stenosis , 2014, Circulation. Cardiovascular imaging.

[38]  O. Barbarash,et al.  Decreased Cathepsin K Plasma Level may Reflect an Association of Osteopoenia/Osteoporosis with Coronary Atherosclerosis and Coronary Artery Calcification in Male Patients with Stable Angina. , 2016, Heart, lung & circulation.

[39]  M. Mizruchi,et al.  Osteocalcin in human serum: a circadian rhythm. , 1985, The Journal of clinical endocrinology and metabolism.

[40]  T. Yamashita,et al.  The serum level of bone-specific alkaline phosphatase activity is associated with aortic calcification in osteoporosis patients , 2004, Journal of Bone and Mineral Metabolism.

[41]  E. McNally,et al.  Genetic pathways of vascular calcification. , 2012, Trends in cardiovascular medicine.

[42]  E. Cavalier,et al.  Vascular calcification: from pathophysiology to biomarkers. , 2015, Clinica chimica acta; international journal of clinical chemistry.

[43]  Serum osteocalcin levels are inversely associated with abdominal aortic calcification in men with type 2 diabetes mellitus , 2013, Osteoporosis International.

[44]  K. Meguro,et al.  Effects on bone metabolism markers and arterial stiffness by switching to rivaroxaban from warfarin in patients with atrial fibrillation , 2017, Heart and Vessels.

[45]  K. Mann,et al.  Noncollagenous bone matrix proteins, calcification, and thrombosis in carotid artery atherosclerosis. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[46]  A. López-Bermejo,et al.  Undercarboxylated osteocalcin relates to cardiovascular risk markers in offspring of families with metabolic syndrome. , 2014, Atherosclerosis.

[47]  W. Edwards,et al.  Calcified Rheumatic Valve Neoangiogenesis Is Associated With Vascular Endothelial Growth Factor Expression and Osteoblast-Like Bone Formation , 2005, Circulation.

[48]  Adam Parr,et al.  Osteocalcin positive mononuclear cells are associated with the severity of aortic calcification. , 2010, Atherosclerosis.

[49]  P. Garnero,et al.  Undercarboxylated osteocalcin measured with a specific immunoassay predicts hip fracture in elderly women: the EPIDOS Study. , 1997, The Journal of clinical endocrinology and metabolism.

[50]  J. Sterne,et al.  The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials , 2011, BMJ : British Medical Journal.

[51]  P. Geusens,et al.  Differential Expression of Bone Matrix Regulatory Proteins in Human Atherosclerotic Plaques , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[52]  G. Gerosa,et al.  Platelets express and release osteocalcin and co‐localize in human calcified atherosclerotic plaques , 2013, Journal of thrombosis and haemostasis : JTH.

[53]  F. Wang,et al.  Serum osteocalcin level and its association with carotid atherosclerosis in patients with type 2 diabetes , 2013, Cardiovascular Diabetology.

[54]  M. Krzanowski,et al.  Relationship between aortic pulse wave velocity, selected proinflammatory cytokines, and vascular calcification parameters in peritoneal dialysis patients , 2014, Journal of hypertension.

[55]  P. Jaśkowski,et al.  Cardiovascular risk in chronic kidney disease patients: intima-media thickness predicts the incidence and severity of histologically assessed medial calcification in radial arteries , 2015, BMC Nephrology.

[56]  A. Terreni,et al.  Biochemical markers in the follow-up of the osteoporotic patients. , 2012, Clinical cases in mineral and bone metabolism : the official journal of the Italian Society of Osteoporosis, Mineral Metabolism, and Skeletal Diseases.

[57]  Y. Bao,et al.  Relationship between serum osteocalcin levels and carotid intima-media thickness in Chinese postmenopausal women , 2013, Menopause.

[58]  R. Eastell,et al.  Measurement of Osteocalcin , 2000, Annals of clinical biochemistry.

[59]  Z. Dai,et al.  An overview of osteocalcin progress , 2016, Journal of Bone and Mineral Metabolism.

[60]  Chun-Hen Pan,et al.  Differential pattern for regulating insulin secretion, insulin resistance, and lipid metabolism by osteocalcin in male and female T2DM patients , 2014, Medical science monitor : international medical journal of experimental and clinical research.

[61]  A. Kraśniak,et al.  Osteoprotegerin as a marker of cardiovascular risk in patients on peritoneal dialysis. , 2013, Polskie Archiwum Medycyny Wewnetrznej.

[62]  T. Liu,et al.  STAT2 hypomorphic mutant mice display impaired dendritic cell development and antiviral response , 2009, Journal of biomedical science.

[63]  K. Watson,et al.  Active serum vitamin D levels are inversely correlated with coronary calcification. , 1997, Circulation.

[64]  D. Bauer,et al.  Association of Osteocalcin and Abdominal Aortic Calcification in Older Women: The Study of Osteoporotic Fractures , 2010, Calcified Tissue International.

[65]  E. Mannarino,et al.  Circulating immature osteoprogenitor cells and arterial stiffening in postmenopausal osteoporosis. , 2011, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[66]  I. Kanazawa,et al.  Relationship between bone biochemical markers versus glucose/lipid metabolism and atherosclerosis; a longitudinal study in type 2 diabetes mellitus. , 2011, Diabetes research and clinical practice.

[67]  K. Park,et al.  Lower uncarboxylated osteocalcin and higher sclerostin levels are significantly associated with coronary artery disease. , 2016, Bone.

[68]  J B Lian,et al.  Osteocalcin and matrix Gla protein: vitamin K-dependent proteins in bone. , 1989, Physiological reviews.

[69]  G. Sumara,et al.  Endocrine Regulation of Male Fertility by the Skeleton , 2011, Cell.

[70]  Weiqing Wang,et al.  Relation of serum osteocalcin level to risk of coronary heart disease in Chinese adults. , 2010, The American journal of cardiology.

[71]  W. Shen,et al.  Mineral metabolism disturbances are associated with the presence and severity of calcific aortic valve disease , 2015, Journal of Zhejiang University-SCIENCE B.

[72]  P. Jaśkowski,et al.  Impaired Fasting Glucose and Diabetes as Predictors for Radial Artery Calcification in End Stage Renal Disease Patients , 2013, International journal of endocrinology.

[73]  Y. Rais,et al.  Bone Gla Protein Increases HIF-1&agr;–Dependent Glucose Metabolism and Induces Cartilage and Vascular Calcification , 2011, Arteriosclerosis, thrombosis, and vascular biology.

[74]  S. Khosla,et al.  Osteocalcin expression by circulating endothelial progenitor cells in patients with coronary atherosclerosis. , 2008, Journal of the American College of Cardiology.

[75]  R. Erbel,et al.  Osteogenic monocytes within the coronary circulation and their association with plaque vulnerability in patients with early atherosclerosis. , 2015, International journal of cardiology.